BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24906388)

  • 1. Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide.
    Gebhardt BJ; Dobelbower MC; Ennis WH; Bag AK; Markert JM; Fiveash JB
    Radiat Oncol; 2014 Jun; 9():130. PubMed ID: 24906388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.
    Dobelbower MC; Burnett Iii OL; Nordal RA; Nabors LB; Markert JM; Hyatt MD; Fiveash JB
    J Med Imaging Radiat Oncol; 2011 Feb; 55(1):77-81. PubMed ID: 21382192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    McDonald MW; Shu HK; Curran WJ; Crocker IR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
    Ogura K; Mizowaki T; Arakawa Y; Ogura M; Sakanaka K; Miyamoto S; Hiraoka M
    Radiat Oncol; 2013 Apr; 8():97. PubMed ID: 24499582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.
    Shields LB; Kadner R; Vitaz TW; Spalding AC
    Radiat Oncol; 2013 Apr; 8():101. PubMed ID: 23618500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.
    Petrecca K; Guiot MC; Panet-Raymond V; Souhami L
    J Neurooncol; 2013 Jan; 111(1):19-23. PubMed ID: 23054563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
    Reddy K; Gaspar LE; Kavanagh BD; Chen C
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):714-21. PubMed ID: 24975917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
    Sherriff J; Tamangani J; Senthil L; Cruickshank G; Spooner D; Jones B; Brookes C; Sanghera P
    Br J Radiol; 2013 Feb; 86(1022):20120414. PubMed ID: 23385995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy.
    Choi SH; Kim JW; Chang JS; Cho JH; Kim SH; Chang JH; Suh CO
    Sci Rep; 2017 Feb; 7():42148. PubMed ID: 28176884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study.
    Pan H; Alksne J; Mundt AJ; Murphy KT; Cornell M; Kesari S; Lawson JD
    Med Oncol; 2012 Sep; 29(3):2040-5. PubMed ID: 22108847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma.
    Yoon SM; Kim JH; Kim SJ; Khang SK; Shin SS; Cho YH; Jwa E; Park JH; Ahn SD
    Tumori; 2013; 99(4):480-7. PubMed ID: 24326836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.
    Paulsson AK; McMullen KP; Peiffer AM; Hinson WH; Kearns WT; Johnson AJ; Lesser GJ; Ellis TL; Tatter SB; Debinski W; Shaw EG; Chan MD
    Am J Clin Oncol; 2014 Apr; 37(2):177-81. PubMed ID: 23211224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.
    Milano MT; Okunieff P; Donatello RS; Mohile NA; Sul J; Walter KA; Korones DN
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1147-55. PubMed ID: 20207495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
    Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
    World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme.
    Ammirati M; Chotai S; Newton H; Lamki T; Wei L; Grecula J
    J Clin Neurosci; 2014 Apr; 21(4):633-7. PubMed ID: 24380758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term experience in high grade glial tumors with temozolomide.
    Demirci U; Buyukberber S; Coskun U; Akmansu M; Yaman E; Baykara M; Yamac D; Uner A; Benekli M
    J BUON; 2012; 17(2):357-62. PubMed ID: 22740218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.